Summary. In view of the marked increase in blood flow into the penis during erection and the association of diabetes mellitus with impotence, we used the diabetic rat model to investigate the possibility that: (a) the penis may produce prostacydin; and (b) prostacyclin secretion may be decreased in diabetes. Rats given a high dose of streptozotocin (120 mg/kg body weight) developed acute ketotic diabetes and were killed after 48 h. Animals given a low dose of streptozotocin (65 rag/ kg body weight) developed non-ketonuric diabetes and were killed after 7 or 62 days. Aortic rings and penile tissue discs were incubated in buffer, which was assayed for 6-oxo-prostaglandin Fla, the stable and spontaneous breakdown product of prostacyclin. Penile tissue from control, ketotic and non-ketonuric (7 days) animals released similar quantities of prostacyclin, whereas that from long-term non-ketonuric animals (62 days) produced significantly less prostacyclin. Production of this prostanoid by the aortic rings paralleled these changes. We conclude that: (a) penile tissue releases prostacyclin in quantities comparable to those of the aorta; (b) long-term diabetes leads to diminished prostacyclin release by penile and aortic tissue: the former may contribute to the pathogenesis of diabetic impotence; and (c) since short-term ketotic diabetes does not inhibit aortic or penile prostacyclin release, duration of diabetes rather than its severity is responsible for diminished prostacyclin release.
The prevalence of sexual impotence in diabetic patients is appreciably greater than that in the normal population [1, 2] . Since penile erection involves considerable and acute vasodilation, with a concomitant increase in blood flow, it is likely that powerful vasodilators are released locally immediately before and during erection. One such vasodilator is vasoactive intestinal polypeptide (VIP). Its release into the penile circulation during erection has already been demonstrated and the relevance of diminished VIP release to the pathogenesis of impotence in diabetic patients has recently been highlighted [3, 4] .
The present study examines the possibility that diabetes may affect any penile production of another vasodilator, prostacyclin (PGI2). Previous data on rats rendered diabetic experimentally show that aortic PGI2 secretion is significantly diminished [5] , suggesting that synthesis of this prostanoid by other vascular organs may also be impaired. Furthermore vascular lesions (e. g. aneurysms, thickening of basement membranes) have been described in penile tissue of diabetic animal models and in patients suffering from impotence associated with diabetes [6] . The penis of the diabetic rat has also been shown to be a representative model for the diabetic human organ [7, 8] . Since the penis has hitherto not been shown to produce PGI2, the present study in-.vestigates: (1) whether PGI2 is produced in large amounts by penile tissue; and (2) the effect of diabetes on penile PGI2 production.
Materials and methods

Acute "ketotie" study
Fourteen 200 g male Sprague Dawley rats were rendered ketotic by an intravenous (tail vein) injection of streptozotocin (120mg/kg body weight) at approximately 11.00 h. Streptozotocin was obtained from Sigma Chemical Company, Poole, Dorset, UK. Urine testing with Multistix (Ames Division, Miles Laboratories, Stoke Poges, Bucks, UK) revealed glycosuria and ketonuria (large amount, > 15.7 mmol/1) within 24 h of administering streptozotocin.
The rats were randomly allocated to three groups:
Group 1 (n = 7). These rats were treated by subcutaneous administration of porcine neutral insulin (3-8 units Actrapid MC, Novo Industri, Copenhagen, Denmark) at 9.00 h and 18.00 h over 3 days, the first injection being given at 18.00 h on day 1, 7 h after inducing diabetes with streptozotocin. The dose of insulin was adjusted so as to reduce Results expressed as mean with range in parentheses, a p < 0.001: control versus diabetic rats; b p<0.002; non-ketonuric diabetes of 62 days duration versus acute ketotic diabetes (untreated); c p < 0.004: non-ketonuric diabetes of 62 days duration versus non-ketonuric diabetes of 7 days duration Results expressed as median with ranges in parentheses ketonuria to < 0.5 mmol/1 (trace) without abolishing glycosuria. On day 3, 48 h after streptozocin and 3 h after their morning insulin injection (09.00 hours), the rats were anaesthetised intraperitoneally with pentobarbital (90 mg/kg, Sagatal, May & Baker, Dagenham, Essex, UK), and tissue and blood samples obtained as described below. Sampling at 48 h was selected, since others [9] as well as ourselves have found that several rats cannot survive for long periods after injection of high doses of streptozotocin.
Group 2 (n = 7)
. These rats were not treated with insulin, but were otherwise treated in the same manner as the rats in group 1.
Group 3 (n = 7)
. This was the control group and consisted of seven matched rats not given streptozotocin. These rats were injected with an appropriate volume of the citrate buffer (pH 4.5) which was used to prepare the streptozocin solutions.
Rats in all groups were allowed free access to food (standard rat chow) and water ad libitum.
Blood was collected by cardiac puncture. Plasma was stored for glucose estimations [10] . Plasma glucose concentrations for each group are shown in Table 1 . Penises were excised and the sheath and fatty tissue removed. The penile tissue was then cut cross-sectionally into 3 mm diameter discs using a scalpel blade and a Teflon block. The rings were rinsed in ice-cold Krebs Ringer bicarbonate buffer (KRB) [11, 12] , which had been pre-gassed to pH 7.4. The discs were randomised and kept in KRB. Discs (50 mg), in duplicate, were incubated in 1 ml KRB at 37 ~ for 60 min in a shaking water bath. After incubation, the tubes were centrifuged (2000 g for 5 rain) and the supernatant stored at -70 ~ The samples were defrosted simultaneously and the concentration of 6-oxo-prostaglandin Faa (6-oxo-PGF~), the stable, spontaneous breakdown product of PGI2, was measured using a specific radioimmunoassay [11, 12] .
Aortic rings from the same animals were also prepared as previously described [11, 12] . The rings were incubated and assayed for 6-oxo-PGFl~ as described for the penile discs.
Chronic " non-ketotic" study
Rats (n = 14, group 4) were rendered diabetic with a lower dose of streptozotocin (65mg/kg body weight) than that described in groups I and 2. Urine was monitored as described above and revealed glycosuria, but no appreciable ketonuria (negative to trace only; 0-0.5 retool/l). After 7 days, seven of these diabetic rats (group 4A) were processed as described above and the results were compared with those observed in seven matched non-diabetic control rats (group 5A). After 62 days, the remaining seven diabetic rats from group 4 (group 4 B) were processed as described above and the results compared with another seven matched non-diabetic control rats (group 5 B).
All rats were allowed free access to food and water; none received any form of treatment. Urine samples were monitored periodically to demonstrate the continued absence of appreciable ketonuria.
Statistical analysis
Results are expressed as median and range and are compared using non-parametric unpaired Mann-Whitney tests (two-tailed) [13] .
Results
The plasma glucose concentrations in all groups are shown in Table 1 .
Acute "ketotic" study 6-oxo-PGFl~ production by penile tissue and aortic tings was similar in the control rats (group 3) and in the insulin-treated and non-treated ketotic rats (groups 1 and 2) ( Table 2) .
Chronic " non-ketotic " study 6-oxo-PGFl~ production by penile tissue and aortic rings in non-ketonuric rats was significantly reduced after 62 days (p< 0.002) (group 4 B), but not after 7 days of diabetes (group 4A) ( Table 3) .
Comparison of all three diabetic groups revealed that the 6-oxo-PGFl~ production by penile tissue and aortic tings of the non-ketonuric diabetic rats of 62 days duration (group4B) was significantly (p <0.002) reduced when compared with the acute ketotic diabetic Results expressed as mean with ranges in parentheses. ~p<0.002: control rats versus non-ketonuric diabetic rats of 62 days duration model (groups 1 and 2, insulin-treated and untreated), or with the non-ketonuric diabetic rats of 7 days duration (group 4A) (Table 3 ) (p < 0.002).
Discussion
Our results show that: (1) rat penile tissue releases substantial amounts of PGI2; (2) penile and aortic PGI2 secretion is not affected by the metabolic disturbance caused by acute ketotic diabetes; and (3) long-standing non-ketonuric diabetes leads to a marked diminution in PGI2 secretion by the rat penis and aorta. Rat aorta appears to produce substantially more PGI2, weight for weight, than the penis. However, direct comparisons must by made with some caution, since we have shown that various forms of trauma, which may occur during preparation of the relevant tissues, influence spontaneous PGI2 release [14] . That a vascular organ like the penis should produce PGI2 is not surprising. However the secretion of this prostanoid by the penis has, to our knowledge, not been demonstrated previously. The exact anatomical location of PGI2 synthesis in the rat penis remains unclear; however, it is of interest that the structure of the corpora cavernosa is very similar to that of blood vessels (smooth muscle; endothelial cells [15] ), which are an established source of PGI2. It is therefore possible that the corpora cavernosa are the principal source of PGI2 in the penis. This view is supported by our preliminary findings that human corpora cavernosa, obtained during penile surgery, release PGI2 (J.Y.Jeremy, unpublished observations). Animal studies involving larger organs are also in progress.
Prostacyclin may well play a functional role in the penis by mediating the acute vasodilation and increase in blood flow during erection. Recent work has shown that the release of another vasodilator, vasoactive intestinal polypeptide (VIP), occurs during penile erection [3, 4] . Furthermore release of VIP, as well as the population of Vipergic nerve endings in the penis, is markedly diminished in impotent males, especially those who have diabetes mellitus [4] . It would clearly be of interest to establish whether PGI2 behaves in a similar manner, and whether VIP (or other substances) stimulates PGI2 release from penile tissue.
Prostacyclin may also play a role in sustaining erection, since it is possible that penile vascular tissue behaves in a manner similar to that of the urinary bladder [12] , and portal [16] and peripheral veins [17] . These respond with an increase in PGI2 production following distension. PGI2, by virtue of its capacity to inhibit platelet aggregation and adhesion [18] , may also play a vital role in maintaining the vascular integrity of the engorged cavernous body.
"Long-term" non-ketonuric diabetes led to a marked diminution in PGI2 release, a result which is in accord with those previously reported for aortic PGI2 production [5] and with the epidemiology of impotence in diabetics [1, 2] . However, the acute and severe metabolic disturbance created by ketotic diabetes had no effect on penile PGI2 production. Any direct analogy with ketoacidosis occurring in vivo has to be guarded, however, since in our experimental model plasma insulin levels are, in fact, raised or within the normal fasting range during the first 24 h [9] . Long-term diabetes may mediate its action by a depletion of PGI2 precursors or by progressive changes in the activities of the enzymes involved in its biosynthesis (e. g., by glycosylation of the enzymes). Alternatively, the "metabolic environment" in the non-ketonuric diabetes of 62 days duration model may be such as to inhibit PGI2 synthesis [19] . This latter view is supported by the observation that the plasma glucose concentrations were significantly higher in the latter group when compared with the other groups of diabetic rats (Table 1 ).
In conclusion, our findings suggest that diabetes is associated with impaired PGI2 production in penile tissue. This deficiency may in turn contribute to the pathogenesis of impotence in diabetics.
